Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Follow-up of Patients With CODMAN CERTAS Plus Programmable Valve

NCT05397106 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.

NCT NCT05397106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05397106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Follow-up of Patients With CODMAN CERTAS Plus Programmable Valve
Lead sponsor
Integra LifeSciences Corporation
Phase
Observational
Overall status
Active, not recruiting
Start date
January 24, 2023
Completion date
January 24, 2029
Enrollment
160 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, hemorrhagic stroke, hydrocephalus, hydrocephalus in children, iih - idiopathic intracranial hypertension, nph (normal pressure hydrocephalus), post-traumatic hydrocephalus